Category: Include on Menu
-

Goldman Sachs to acquire Neos Investments in deal worth up to $2.25 billion
Goldman Sachs Group Inc. (NYSE:GS) has agreed to acquire Neos Investments for up to $2.25 billion in cash and equity, expanding the Wall Street bank’s position in the rapidly growing actively managed exchange-traded fund market, according to a Bloomberg report on Wednesday. The transaction will add Neos’s expanding portfolio of ETFs to Goldman Sachs Asset…
-

Ituran beats Q2 forecasts as revenue reaches record $104.8 million
Ituran Location and Control Ltd. (NASDAQ:ITRN) reported second-quarter earnings and revenue above Wall Street expectations on Wednesday, supported by strong growth in its recurring subscription business and continued expansion of its subscriber base. The shares showed little movement in after-hours trading following the announcement. Adjusted earnings per share reached $0.88, beating the analyst consensus estimate…
-

Riskified shares surge after revenue beat and upgraded full-year guidance
Riskified Ltd. (NYSE:RSKD) shares jumped 7% in premarket trading on Wednesday after the ecommerce fraud and risk intelligence company delivered second-quarter revenue well above Wall Street expectations and raised its full-year outlook. Adjusted earnings per share came in at $0.02, matching analyst estimates. Revenue climbed 22% year on year to $98.7 million, comfortably exceeding the…
-

Perma-Fix secures Hanford waste subcontract under $4.37 billion programme
Perma-Fix Environmental Services (NASDAQ:PESI) has secured a Master Indefinite Delivery/Indefinite Quantity subcontract from Hanford Tank Waste Operations & Closure, LLC (H2C) covering the treatment and disposal of pretreated liquid mixed low-level waste from the U.S. Department of Energy’s Hanford Site in southeastern Washington State. The subcontract became effective on August 11, 2026, and allows H2C…
-

Milestone Pharmaceuticals shares tumble after Q2 earnings miss
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) shares dropped 12.60% on Wednesday after the biopharmaceutical company reported a second-quarter loss that was wider than Wall Street expected, despite continued progress with the commercial launch of CARDAMYST. For the quarter ended June 30, 2026, Milestone recorded an adjusted loss of $0.21 per share, compared with the analyst consensus forecast…
-

Brinker International shares dip after earnings miss despite strong 2027 guidance
Brinker International, Inc. (NYSE:EAT) shares fell 1.98% in premarket trading after the parent company of Chili’s Grill & Bar and Maggiano’s Little Italy reported fiscal fourth-quarter earnings slightly below Wall Street expectations, although its outlook for fiscal 2027 came in well ahead of forecasts. Adjusted earnings per share reached $3.07 for the quarter ended June…
-

Definium Therapeutics shares surge after positive Phase 3 anxiety trial results
Definium Therapeutics (NASDAQ:DFTX) shares jumped 20% in premarket trading on Wednesday after the company announced positive topline results from its Phase 3 Voyage study evaluating DT120 ODT in patients with generalised anxiety disorder. The trial achieved its primary endpoint as well as all key secondary efficacy endpoints, providing another positive late-stage clinical result for the…
-

Unicycive Therapeutics shares rise after second-quarter loss beats forecasts
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares gained 2.00% in premarket trading on Wednesday after the clinical-stage biotechnology company reported a second-quarter loss that was considerably narrower than Wall Street expected. The company posted a loss of $0.06 per share for the quarter, compared with the analyst consensus forecast for a loss of $0.48 per share. Unicycive,…
-

Local Bounti shares fall after second-quarter revenue misses forecasts
Local Bounti Corporation (NYSE:LOCL) shares fell 4.76% in premarket trading after the indoor agriculture company reported second-quarter revenue and adjusted earnings below Wall Street expectations, despite delivering year-on-year sales growth and reducing its losses. Revenue reached $13.9 million, well below the analyst consensus estimate of $22 million. The company reported an adjusted loss of $0.68…
-

Madison Square Garden Entertainment shares rise after Q4 results beat forecasts
Madison Square Garden Entertainment Corp. (NYSE:MSGE) shares gained 3.31% in premarket trading on Wednesday after the live entertainment company reported fiscal fourth-quarter earnings and revenue above Wall Street expectations. The company posted a quarterly loss of $0.21 per share, considerably narrower than the analyst consensus forecast for a loss of $0.58 per share. Revenue climbed…